Výsledky vyhledávání

Editorial & Opinion

Response to Crudele et al. Commentary on Mayock et al. "In Vitro Drug Release after Crushing: Evaluation of Xtampza ^® ER and Other ER Opioid Formulations".

Autor: Fleming AB; Collegium Pharmaceutical, Inc., Canton, MA, USA. afleming@collegiumpharma.com., Mayock SP; Collegium Pharmaceutical, Inc., Canton, MA, USA., Saim S; Collegium Pharmaceutical, Inc., Canton, MA, USA.

Publikováno v: Clinical drug investigation [Clin Drug Investig] 2018 Aug; Vol. 38 (8), pp. 799-800.

Zobrazit plný text záznamu

Akademický článek

Author Correction to: In Vitro Drug Release After Crushing: Evaluation of Xtampza ^® ER and Other ER Opioid Formulations.

Autor: Mayock SP; Collegium Pharmaceutical, Inc., 780 Dedham St, Ste 800, Canton, MA, 02021, USA., Saim S; Collegium Pharmaceutical, Inc., 780 Dedham St, Ste 800, Canton, MA, 02021, USA., Fleming AB; Collegium Pharmaceutical, Inc., 780 Dedham St, Ste 800, Canton, MA, 02021, USA. afleming@collegiumpharma.com.

Publikováno v: Clinical drug investigation [Clin Drug Investig] 2017 Dec; Vol. 37 (12), pp. 1203.

Zobrazit plný text záznamu

Akademický článek

In Vitro Drug Release After Crushing: Evaluation of Xtampza ^® ER and Other ER Opioid Formulations.

Publikováno v: Clinical drug investigation [Clin Drug Investig] 2017 Dec; Vol. 37 (12), pp. 1117-1124.

Zobrazit plný text záznamu

Akademický článek

Evaluation of an Extended-Release, Abuse-Deterrent, Microsphere-in-Capsule Analgesic for the Management of Patients with Chronic Pain With Dysphagia (CPD).

Autor: Fleming AB; Collegium Pharmaceutical, Inc., Canton, MA, U.S.A., Carlson DR; Collegium Pharmaceutical, Inc., Canton, MA, U.S.A., Varanasi RK; Collegium Pharmaceutical, Inc., Canton, MA, U.S.A., Grima M; Collegium Pharmaceutical, Inc., Canton, MA, U.S.A., Mayock SP; Collegium Pharmaceutical, Inc., Canton, MA, U.S.A., Saim S; Collegium Pharmaceutical, Inc., Canton, MA, U.S.A., Kopecky EA; Collegium Pharmaceutical, Inc., Canton, MA, U.S.A.

Publikováno v: Pain practice : the official journal of World Institute of Pain [Pain Pract] 2016 Mar; Vol. 16 (3), pp. 334-44. Date of Electronic Publication: 2015 Jan 12.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

In vitro assessment of the potential for abuse via the intravenous route of oxycodone DETERx® microspheres.

Autor: Fleming AB; Collegium Pharmaceutical, Inc., Canton, Massachusetts., Scungio TA; Collegium Pharmaceutical, Inc., Canton, Massachusetts., Grima MP; Collegium Pharmaceutical, Inc., Canton, Massachusetts., Mayock SP; Collegium Pharmaceutical, Inc., Canton, Massachusetts.

Publikováno v: Journal of opioid management [J Opioid Manag] 2016 Jan-Feb; Vol. 12 (1), pp. 57-65.

Zobrazit plný text záznamu

Akademický článek

Impact of physical manipulation on in vitro and in vivo release profiles of oxycodone DETERx®: an extended-release, abuse-deterrent formulation.

Autor: Kopecky EA; Collegium Pharmaceutical, Inc., Canton, Massachusetts., Fleming AB; Collegium Pharmaceutical, Inc., Canton, Massachusetts., Noonan PK; PK Noonan & Associates, Williamsburg, Virginia., Varanasi RK; Collegium Pharmaceutical, Inc., Canton, Massachusetts., Grima M; Collegium Pharmaceutical, Inc., Canton, Massachusetts., Saim S; Collegium Pharmaceutical, Inc., Canton, Massachusetts., Mayock SP; Collegium Pharmaceutical, Inc., Canton, Massachusetts.

Publikováno v: Journal of opioid management [J Opioid Manag] 2014 Jul-Aug; Vol. 10 (4), pp. 233-46.

Zobrazit plný text záznamu

Akademický článek

Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to Access.

Autor: Webster, Lynn, Gudin, Jeffrey

Publikováno v: Journal of Pain Research; Jun2024, Vol. 17, p1989-2000, 12p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání